From Isis CEO Vows that Cholesterol Drug, Partnered With Genzyme, Will be “Remarkable” Advance:

CrookeMug

CrookeMug—

Stanley Crooke is CEO of Isis Pharmaceuticals

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
How to Approach Life Sciences Fundraising
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

Sponsored · Webinar
Using Enzyme Fragment Complementation (EFC) Technology to Quantify Reporter Gene Activity
Robust, sensitive, & easy-to-use cell-based, reporter gene assays to study signaling pathways
Eurofins DiscoverX

From Our Editors · Podcast
Xcelerating Life Sciences San Diego: The Highlights Podcast
Learn what's fueling San Diego's biotech investment and partnership opportunities

Xconomy on Demand

We offer a number of ways to subscribe for free!